Novel mutations of low-density lipoprotein receptor gene in China patients with familial hypercholesterolemia

Appl Biochem Biotechnol. 2015 May;176(1):101-9. doi: 10.1007/s12010-015-1554-x. Epub 2015 Apr 7.

Abstract

Familial hypercholesterolaemia (FH) is an autosomal dominant genetic disorder, associated with elevated level of serum low-density lipoprotein-cholesterol (LDL-C), which can lead to premature cardiovascular disease (CVD). Mutations in low density lipoprotein receptor (LDLR) and proprotein convertase subtilisin/kexin type 9 (PCSK9) have been identified to be the underlying cause of this disease. Genetic research of FH has already been extensively studied all over the world. However, reports of FH mutations in the Chinese population are still limited. In this paper, 20 unrelated FH families were enrolled to detect the candidate gene variants in Chinese FH population by DNA direct sequencing. We identified 12 LDLR variants in 13 FH probands. Importantly, we first reported two unique mutations (c.2000_2000 delG/p.C667LfsX6 and c.605T>C/p.F202S) in LDLR gene. Our discoveries expand the spectrum of LDLR mutations and contribute to the genetic diagnosis and counseling for FH patients.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Asian People
  • Child
  • Child, Preschool
  • China
  • Female
  • Humans
  • Hyperlipoproteinemia Type II / genetics*
  • Male
  • Middle Aged
  • Mutation*
  • Receptors, LDL / genetics*
  • Young Adult

Substances

  • LDLR protein, human
  • Receptors, LDL